Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis. Numerous randomized, controlled trials have demonstrated that recombinant human erythropoietin (rHuEPO, epoetin alfa) significantly raises hemoglobin levels, reduces transfusion requirements, and i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2004-03, Vol.65 (3), p.757-767
Hauptverfasser:	Jones, Michael, Ibels, Lloyd, Schenkel, Brad, Zagari, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	anemia Anemia - drug therapy Anemia - etiology Biological and medical sciences chronic renal failure Epoetin Alfa Erythropoietin - therapeutic use Hematinics - therapeutic use hospitalization Humans Kidney Failure, Chronic - complications Medical sciences meta-analysis Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure quality of life Recombinant Proteins Renal failure transfusion
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!